IonQ stock experiences 2.5% decline due to short-seller report and legal investigation

IonQ Inc (NYSE:IONQ | IONQ Price Prediction) experienced a 2.5% decrease in share value this week, contrasting with the slight drops of both the SPDR S&P 500 ETF Trust (NYSEARCA:SPY) and the Invesco QQQ Trust (NASDAQ:QQQ) at 1.3%. Despite the decline, IonQ saw a 9% rally on Friday, offering some relief to investors who have been enduring a steady stream of sell-offs since the middle of October.

The company’s acquisition of SkyWater Technology (SKYT) for $1.8 billion at the end of January failed to stabilize IonQ’s stocks, as they have plummeted by 27% since the announcement. While Wall Street continues to hold optimistic views on IonQ, there is mounting pressure for the company to demonstrate revenue growth as the market loses interest in momentum-driven stocks.

IonQ shares closed at $34.11 on Friday, marking a 24% loss since the beginning of the year. Throughout the year, the stock has dropped 33%, falling significantly below its 52-week highs. Despite this alarming trend, IonQ is still ahead of many quantum competitors in the market.

This week was marked by three critical developments: a contentious report from a short-seller, a major acquisition that unsettled investors, and a growing disparity between analyst confidence and market performance. The short-seller’s report on February 6 raised concerns about IonQ’s revenue reporting methods and the reliance on U.S. defense funding. This led to an 11% drop in stock value post-release and prompted a securities fraud investigation into the company’s revenue practices.

IonQ’s acquisition of SkyWater Technology for $1.8 billion was met with skepticism from investors, resulting in a 28% decrease in share price since the announcement. While management aims to create an all-encompassing quantum platform through strategic acquisitions, concerns about cash flow, dilution, and integration risks are prevalent among investors.

Despite these challenges, Wall Street analysts maintain a positive outlook on IonQ, with a consensus Moderate Buy rating and an average price target of $75.91, suggesting a potential 127% upside. However, with IonQ trading at 141x sales and burning through $408 million in EBITDA annually, achieving revenue growth targets is crucial for the company to reverse negative market sentiment.

As IonQ prepares to disclose its Q4 and full-year 2025 results on February 25, investors are eagerly waiting to see if the company can deliver on its promises and bridge the gap between analyst expectations and market performance. With quantum stocks facing increased skepticism from the market, the pressure is on for IonQ to demonstrate tangible results moving forward.